- Home
- PRME vs FLGT Comparison
PRME vs FLGT Comparison
Compare PRME & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- FLGT
- Stock Information
- Founded
- PRME 2019
- FLGT 2011
- Country
- PRME United States
- FLGT United States
- Employees
- PRME N/A
- FLGT N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- FLGT Medical Specialities
- Sector
- PRME Health Care
- FLGT Health Care
- Exchange
- PRME Nasdaq
- FLGT Nasdaq
- Market Cap
- PRME 693.5M
- FLGT 587.3M
- IPO Year
- PRME 2022
- FLGT 2016
- Fundamental
- Price
- PRME $4.67
- FLGT $21.94
- Analyst Decision
- PRME Buy
- FLGT Buy
- Analyst Count
- PRME 6
- FLGT 3
- Target Price
- PRME $8.88
- FLGT $25.33
- AVG Volume (30 Days)
- PRME 2.9M
- FLGT 197.0K
- Earning Date
- PRME 11-11-2025
- FLGT 11-07-2025
- Dividend Yield
- PRME N/A
- FLGT N/A
- EPS Growth
- PRME N/A
- FLGT N/A
- EPS
- PRME N/A
- FLGT N/A
- Revenue
- PRME $4,961,000.00
- FLGT $303,223,000.00
- Revenue This Year
- PRME $179.58
- FLGT $15.19
- Revenue Next Year
- PRME N/A
- FLGT $10.58
- P/E Ratio
- PRME N/A
- FLGT N/A
- Revenue Growth
- PRME 739.42
- FLGT 4.31
- 52 Week Low
- PRME $1.11
- FLGT $14.57
- 52 Week High
- PRME $5.17
- FLGT $23.56
- Technical
- Relative Strength Index (RSI)
- PRME 67.60
- FLGT 56.74
- Support Level
- PRME $3.09
- FLGT $21.49
- Resistance Level
- PRME $4.18
- FLGT $22.37
- Average True Range (ATR)
- PRME 0.31
- FLGT 0.55
- MACD
- PRME 0.11
- FLGT -0.10
- Stochastic Oscillator
- PRME 98.14
- FLGT 50.00
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About FLGT Fulgent Genetics Inc.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.